EP Patent

EP1301221B1 — Process for coating medical devices using super-critical carbon dioxide

Assigned to Janssen Pharmaceuticals Inc · Expires 2006-02-15 · 20y expired

What this patent protects

This invention provides an improved process for coating medical and surgical devices and the like using super-critical fluids.

USPTO Abstract

This invention provides an improved process for coating medical and surgical devices and the like using super-critical fluids.

Drugs covered by this patent

Patent Metadata

Patent number
EP1301221B1
Jurisdiction
EP
Classification
—
Expires
2006-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.